Metastatic Papillary Thyroid Cancer to the Liver: The Central Role of a Multidisciplinary Approach to Treatment.

Ochsner J · 2021 · PMC8238104 · PMID 34239388

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

21 The group treated with lenvatinib had a highly significant PFS advantage of 18.3 vs 3.6 months in the placebo group.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.